NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
82 hedge funds and large institutions have $47.1M invested in Novelion Therapeutics Inc. Common Shares in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
51% less call options, than puts
Call options by funds: $50K | Put options by funds: $103K
53% less capital invested
Capital invested by funds: $99.3M → $47.1M (-$52.2M)
Holders
82
Holding in Top 10
2
Calls
$50K
Puts
$103K
Top Buyers
| 1 | +$3.6M | |
| 2 | +$749K | |
| 3 | +$370K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$229K |
| 5 |
Morgan Stanley
New York
|
+$220K |
Top Sellers
| 1 | -$6.03M | |
| 2 | -$411K | |
| 3 | -$361K | |
| 4 |
LCS
Levin Capital Strategies
New York
|
-$334K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$225K |